China Pioneer Pharma Holdings Limited

Symbol: 1345.HK

HKSE

1.42

HKD

Market price today

  • 13.7445

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 1.67B

    MRK Cap

  • 0.04%

    DIV Yield

China Pioneer Pharma Holdings Limited (1345-HK) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.43%

Operating Profit Margin

0.09%

Net Profit Margin

0.09%

Return on Assets

0.10%

Return on Equity

0.15%

Return on Capital Employed

0.12%

Company general description and statistics

Sector: Healthcare
Industry: Pharmaceutical Retailers
CEO:Mr. Yuewen Yang
Full-time employees:361
City:Shanghai
Address:No.15, Lane 88 Wuwei Road
IPO:2013-11-05
CIK:

China Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. It has a portfolio of pharmaceutical products, such as ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas, as well as medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company sells its products to hospitals and medical institutions, and pharmacies. It also sells ancillary tools and leases accessories; and sells dental devices. In addition, the company engages in the sale of imported in-licensed prescription products. China Pioneer Pharma Holdings Limited was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. China Pioneer Pharma Holdings Limited is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.

General Outlook

When we look at how much money they make before expenses, they keep 0.427% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.085%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.093%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.095% return, is a testament to China Pioneer Pharma Holdings Limited's adeptness in optimizing resource deployment. China Pioneer Pharma Holdings Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.147%. Furthermore, the proficiency of China Pioneer Pharma Holdings Limited in capital utilization is underscored by a remarkable 0.123% return on capital employed.

Stock Prices

China Pioneer Pharma Holdings Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1.78, while its low point bottomed out at $1.78. This variance in figures offers investors a lucid insight into the roller-coaster ride that is China Pioneer Pharma Holdings Limited's stock market.

Liquidity Ratios

Analyzing 1345.HK liquidity ratios reveals its financial health of the firm. The current ratio of 250.05% gauges short-term asset coverage for liabilities. The quick ratio (129.40%) assesses immediate liquidity, while the cash ratio (25.85%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio250.05%
Quick Ratio129.40%
Cash Ratio25.85%

Profitability Ratios

1345.HK profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 11.52% underscores its earnings before tax deductions. The effective tax rate stands at 28.51%, revealing its tax efficiency. The net income per EBT, 80.75%, and the EBT per EBIT, 135.12%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 8.52%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin11.52%
Effective Tax Rate28.51%
Net Income per EBT80.75%
EBT per EBIT135.12%
EBIT per Revenue8.52%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.50, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding129
Days of Inventory Outstanding170
Operating Cycle274.26
Days of Payables Outstanding116
Cash Conversion Cycle158
Receivables Turnover3.49
Payables Turnover3.15
Inventory Turnover2.15
Fixed Asset Turnover6.33
Asset Turnover1.02

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.10, and free cash flow per share, -0.13, depict cash generation on a per-share basis. The cash per share value, 0.11, showcases liquidity position. A payout ratio of 0.53 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, -0.08, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.10
Free Cash Flow per Share-0.13
Cash per Share0.11
Payout Ratio0.53
Operating Cash Flow Sales Ratio-0.08
Free Cash Flow to Operating Cash Flow Ratio1.26
Cash Flow Coverage Ratio-1.60
Short Term Coverage Ratio-1.94
Capital Expenditure Coverage Ratio-3.84
Dividend Paid and Capex Coverage Ratio-1.09
Dividend Payout Ratio0.04

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 4.84%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.07, we discern the balance between debt and equity financing. The long-term debt to capitalization, 1.25%, and total debt to capitalization, 6.85%, ratios shed light on its capital structure.

cards.indicatorcards.value
Debt Ratio4.84%
Debt Equity Ratio0.07
Long Term Debt to Capitalization1.25%
Total Debt to Capitalization6.85%
Cash Flow to Debt Ratio-1.60
Company Equity Multiplier1.52

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.33, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.12, reflects the portion of profit attributed to each share. The book value per share, 0.85, represents the net asset value distributed per share, while the tangible book value per share, 0.83, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share1.33
Net Income Per Share0.12
Book Value Per Share0.85
Tangible Book Value Per Share0.83
Shareholders Equity Per Share0.85
Interest Debt Per Share0.06
Capex Per Share-0.04

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 0.68%, indicates top-line expansion, while the gross profit growth, -14.38%, reveals profitability trends. EBIT growth, -42.49%, and operating income growth, -42.49%, offer insights into operational profitability progression. The net income growth, -38.07%, showcases bottom-line expansion, and the EPS growth, -40.00%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth0.68%
Gross Profit Growth-14.38%
EBIT Growth-42.49%
Operating Income Growth-42.49%
Net Income Growth-38.07%
EPS Growth-40.00%
EPS Diluted Growth-40.00%
Weighted Average Shares Growth-1.04%
Weighted Average Shares Diluted Growth-1.04%
Dividends per Share Growth-7.48%
Operating Cash Flow Growth-227.22%
Free Cash Flow Growth-958.04%
10-Year Revenue Growth per Share9.45%
5-Year Revenue Growth per Share2.28%
3-Year Revenue Growth per Share20.83%
10-Year Operating CF Growth per Share-320.06%
5-Year Operating CF Growth per Share-197.82%
3-Year Operating CF Growth per Share-264.24%
10-Year Net Income Growth per Share-45.67%
5-Year Net Income Growth per Share82.66%
3-Year Net Income Growth per Share185.43%
10-Year Shareholders Equity Growth per Share-22.72%
5-Year Shareholders Equity Growth per Share-3.38%
3-Year Shareholders Equity Growth per Share13.69%
10-Year Dividend per Share Growth per Share-70.00%
3-Year Dividend per Share Growth per Share-63.42%
Receivables Growth8.54%
Inventory Growth30.14%
Asset Growth-2.59%
Book Value per Share Growth0.92%
Debt Growth96.90%
SGA Expenses Growth-2.47%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,913,674,790.153, captures the company's total value, considering both debt and equity. Income quality, -0.66, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 2.38%, indicates the value of non-physical assets, and capex to operating cash flow, 37.54%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value1,913,674,790.153
Income Quality-0.66
Sales General and Administrative to Revenue0.07
Intangibles to Total Assets2.38%
Capex to Operating Cash Flow37.54%
Capex to Revenue-2.84%
Capex to Depreciation-235.12%
Graham Number1.54
Return on Tangible Assets9.75%
Graham Net Net0.13
Working Capital664,239,000
Tangible Asset Value981,363,000
Net Current Asset Value593,791,000
Average Receivables430,786,000
Average Payables307,147,500
Average Inventory369,533,000
Days Sales Outstanding104
Days Payables Outstanding116
Days of Inventory On Hand170
ROIC8.84%
ROE0.14%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.99, and the price to book ratio, 1.99, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.35, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -14.18, and price to operating cash flows, -16.87, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.99
Price to Book Ratio1.99
Price to Sales Ratio1.35
Price Cash Flow Ratio-16.87
Enterprise Value Multiple14.32
Price Fair Value1.99
Price to Operating Cash Flow Ratio-16.87
Price to Free Cash Flows Ratio-14.18
Price to Tangible Book Ratio1.94
Enterprise Value to Sales1.22
Enterprise Value Over EBITDA9.57
EV to Operating Cash Flow-16.12
Earnings Yield7.46%
Free Cash Flow Yield-8.35%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of China Pioneer Pharma Holdings Limited (1345.HK) on the HKSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 13.744 in 2024.

What is the ticker symbol of China Pioneer Pharma Holdings Limited stock?

The ticker symbol of China Pioneer Pharma Holdings Limited stock is 1345.HK.

What is company IPO date?

IPO date of China Pioneer Pharma Holdings Limited is 2013-11-05.

What is company current share price?

Current share price is 1.420 HKD.

What is stock market cap today?

The market cap of stock today is 1671587080.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 361.